Research ArticleArticle
Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
Drug Metabolism and Disposition March 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294
Ulf G. Eriksson
Ulf Bredberg
Kurt-Jürgen Hoffmann
Anneli Thuresson
Margareth Gabrielsson
Hans Ericsson
Martin Ahnoff
Kristina Gislén
Gunnar Fager
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Drug Metabolism and Disposition
Vol. 31, Issue 3
1 Mar 2003
Research ArticleArticle
Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
Drug Metabolism and Disposition March 1, 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294
Research ArticleArticle
Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
Ulf G. Eriksson, Ulf Bredberg, Kurt-Jürgen Hoffmann, Anneli Thuresson, Margareth Gabrielsson, Hans Ericsson, Martin Ahnoff, Kristina Gislén, Gunnar Fager and David Gustafsson
Drug Metabolism and Disposition March 1, 2003, 31 (3) 294-305; DOI: https://doi.org/10.1124/dmd.31.3.294
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement